Gut microbiota-mediated choline metabolism exacerbates cognitive impairment induced by chronic cerebral hypoperfusion
- PMID: 39719076
- PMCID: PMC12035329
- DOI: 10.1177/0271678X241309777
Gut microbiota-mediated choline metabolism exacerbates cognitive impairment induced by chronic cerebral hypoperfusion
Abstract
Chronic cerebral hypoperfusion (CCH) is a crucial mechanism causing vascular cognitive impairment (VCI). Choline is metabolized by gut microbiota into trimethylamine N-oxide (TMAO), a risk factor of cardiovascular diseases and cognitive impairment. However, the impact of choline-TMAO pathway on CCH-induced VCI is elusive. We performed a cross-sectional clinical study to investigate the relationship between the choline-TMAO pathway and cognitive outcome and used a bilateral common carotid artery occlusion rat model to explore the effect of a choline-rich diet on cognition and underlying mechanisms. Plasma choline and TMAO levels were negatively correlated with cognitive scores in CCH patients. A choline-rich diet exacerbated CCH-induced cognitive impairment by encouraging the proliferation of choline-metabolizing bacteria in the gut and subsequent generation of TMAO. The choline-TMAO pathway, mediated by gut microbiota, exacerbates cognitive impairment induced by CCH. Targeted dietary choline regulation based on gut microbiota modulation may ameliorate long-term cognitive impairment.
Keywords: Choline; chronic cerebral hypoperfusion; cognitive impairment; gut microbiota; trimethylamine N-oxide.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Dl-3-n-Butylphthalide Alleviates Cognitive Impairment in Chronic Cerebral Hypoperfusion: Associations with Mitochondrial Permeability Transition Pore Closure and Suppression of Excessive Mitophagy.ACS Chem Neurosci. 2025 Jun 18;16(12):2208-2216. doi: 10.1021/acschemneuro.4c00826. Epub 2025 May 29. ACS Chem Neurosci. 2025. PMID: 40440567 Free PMC article.
-
Association of the gut microbe-dependent trimethylamine N-oxide and its precursors with risk of hypertension: a cross-sectional study in rural northeastern China.Nutr Metab Cardiovasc Dis. 2025 Sep;35(9):104032. doi: 10.1016/j.numecd.2025.104032. Epub 2025 Apr 2. Nutr Metab Cardiovasc Dis. 2025. PMID: 40287312
-
Dietary choline deficiency potentiates Helicobacter pylori-driven gut-liver dysfunction via microbial metabolic rewiring.Int Immunopharmacol. 2025 Aug 28;161:115050. doi: 10.1016/j.intimp.2025.115050. Epub 2025 Jun 12. Int Immunopharmacol. 2025. PMID: 40505229
-
Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis.Nutr J. 2025 Jun 16;24(1):91. doi: 10.1186/s12937-025-01159-9. Nutr J. 2025. PMID: 40524200 Free PMC article. Review.
-
Trimethylamine N-oxide reduction is related to probiotic strain specificity: A systematic review.Nutr Res. 2022 Aug;104:29-35. doi: 10.1016/j.nutres.2022.04.001. Epub 2022 Apr 10. Nutr Res. 2022. PMID: 35588611
References
-
- Jia L, Du Y, Chu L, et al.. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 2020; 5: e661–e671. - PubMed
-
- van der Flier WM, Skoog I, Schneider JA, et al.. Vascular cognitive impairment. Nat Rev Dis Primers 2018; 4: 18003. - PubMed
-
- Duncombe J, Kitamura A, Hase Y, et al.. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci (Lond) 2017; 131: 2451–2468. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical